Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Financial Statement Detail (Tables)

v2.4.0.8
Condensed Consolidated Financial Statement Detail (Tables)
 3 Months Ended
Mar. 31, 2014
Condensed Consolidated Financial Statement Detail [Abstract]  
Outstanding securities considered anti-dilutive
The following table shows the total outstanding securities considered anti-dilutive and therefore excluded from the computation of diluted net loss per share (in thousands):

 
  
Three Months Ended March 31,
  
 
  
2014
    
2013
  
Common stock options and restricted stock units
    
5,732
      
6,459
  
Warrants for common stock
    
14,273
      
16,176
  
Total
    
20,005
      
22,635
  

Reconciliation of numerators and denominators of basic and diluted net loss per share
For the three months ended March 31, 2014, the following is a reconciliation of the numerators and denominators of the basic and diluted net loss per share of common stock (in thousands):
 
 
  
3 Months Ended March 31, 2014
  
Numerator
  
 
Net loss originally reported
    
(4,687
)
Correction - removal of revaluation of contingent warrant liabilities
    
(19,534
)
Numerator for use in diluted loss per share of common stock - restated
    
(24,221
)
Denominator
        
Weighted average shares outstanding used for diluted net loss per share of common stock originally reported
    
106,158
  
Correction - effect of dilutive warrants
    
9,366
  
Denominator for use in diluted loss per share of common stock - restated
    
115,524
  

Accrued liabilities
Accrued liabilities consisted of the following at March 31, 2014 and December 31, 2013 (in thousands):

 
  
March 31,
2014
    
December 31,
2013
  
Accrued payroll and other benefits
  
$
2,401
    
$
3,009
  
Accrued management incentive compensation
    
1,050
      
4,386
  
Other
    
1,444
      
2,539
  
Total
  
$
4,895
    
$
9,934